Acute Ischemic and Hemorrhagic Stroke and COVID-19: Case Series
- PDF / 868,928 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 0 Downloads / 200 Views
COVID-19
Acute Ischemic and Hemorrhagic Stroke and COVID-19: Case Series Poya Fatehi 1 & Negin Hesam-Shariati 2 & Morteza Abouzaripour 3 & Fardin Fathi 4 & Mohammad Bakhtiar Hesam Shariati 3 Accepted: 28 September 2020 # Springer Nature Switzerland AG 2020
Abstract The coronavirus COVID-19 pandemic is the defining global health crisis of our time and the greatest challenge we have faced since the World Wars; it can attack several systems in the body and has high complications and mortality. COVID19 can cause venous and arterial thromboembolism due to immobility, high inflammation, extensive intravascular blood coagulation, and hypoxia. In this study, we report 5 cases of adults with COVID-19, hospitalized in Tohid Hospital, Sanandaj, Iran. Three patients were male and two were female. The youngest patient was 20 years old and the oldest was 55 years old. All patients had at least one family member with coronavirus. Fever, chills, muscular pain, cough, and tachypnea were present in all patients. Red blood cell (RBC) was observed in all patients at a low level. Computed tomography (CT) scans of all patients showed abnormal findings in different areas of the brain. These cases indicate that COVID-19 may damage blood vessels in the brain and lead to stroke. Keywords Coronavirus . Ischemic . COVID-19 . Stroke . Computed tomography
Introduction COVID-19 (coronavirus) is a viral respiratory disease, which has infected many people around the world in the past 6 months. The World Health Organization (WHO) declared COVID-19 as a global health emergency in January 2020 [1]. Dry cough and fever are two of the most common symptoms of this disease, which can cause complications such as chest pain, acute respiratory distress syndrome (ARDS), and vascular insufficiency [2]. Factors such as old age, hypertension, diabetes, neutrophilia, lymphocytopenia, high inflammatory indicators, and blood coagulation disorders are the key agents This article is part of the Topical Collection on Covid-19 * Mohammad Bakhtiar Hesam Shariati [email protected]; [email protected] 1
Department of Radiology, Tohid Hospital, Kurdistan University of Medical Sciences, Sanandaj, Iran
2
School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia
3
Department of Anatomical Sciences, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
4
Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
in causing death and respiratory distress in patients with COVID-19 [1]. There is ample evidence that the COVID-19 effects are not always limited to the respiratory system but can also impair the cardiovascular, gastrointestinal, urinary, reproductive, and nervous systems [3, 4]. Symptoms of coronavirus affecting the nervous system can be classified into three groups: (1) symptoms of central nervous system that include headache, vertigo, acute cerebrovascular disease, and epilepsy; (2) symptoms of pe
Data Loading...
